Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: A two-year study
Authors:
- Yusuf A. RajaballyYRYusuf A. Rajabally
- David A. KearneyDKDavid A. Kearney
- 1 September 2011
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 308 (1-2) , 124-127
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First RevisionEuropean Journal of Neurology, 2010
- A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathyEuropean Journal of Neurology, 2010
- Case-control study of thromboembolic events associated with IV immunoglobulinJournal of Neurology, 2009
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy*European Journal of Neurology, 2006
- Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literatureBritish Journal of Dermatology, 2006
- Acute inflammatory demyelinating polyneuropathy: Contribution of a dispersed distal compound muscle action potential to electrodiagnosisMuscle & Nerve, 2006
- Intravenous Immunoglobulin: Adverse Effects and Safe AdministrationClinical Reviews in Allergy & Immunology, 2005
- Side effects of intravenous immunoglobulins in neurological autoimmune disordersJournal of Neurology, 2003
- Reversible encephalopathy with cerebral vasospasm in a Guillain-Barre syndrome patient treated with intravenous immunoglobulinNeurology, 1996
- High‐dose intravenous immunoglobulin and serum viscosityNeurology, 1994